Steris (STE) Liabilities from Discontinued Operations (2023 - 2024)

Steris' (STE) quarterly Liabilities from Discontinued Operations came in at 64012000.0 in Q1 2024, up 26.4% year-on-year from 50642000.0 in Q2 2023, and up 26.4% quarter-over-quarter from 50642000.0 in Q1 2023.

Steris (STE) Liabilities from Discontinued Operations (2023 - 2024) Analysis & Trends

Steris' Liabilities from Discontinued Operations history runs 2 years deep, the most recent figure standing at 64012000.0 for Q1 2024.

  • On a quarterly basis, Liabilities from Discontinued Operations rose 26.4% year-over-year to 64012000.0 in Q1 2024; TTM through Mar 2024 was 64012000.0, a 26.4% increase from a year earlier, with the FY2024 full-year figure at 64012000.0, up 26.4% from the prior year.
  • Liabilities from Discontinued Operations advanced to 64012000.0 in Q1 2024 per STE's latest filing, from 50642000.0 in the prior quarter.
  • Across five years, Liabilities from Discontinued Operations topped out at 64012000.0 in Q1 2024 and bottomed at 50642000.0 in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2024 64.01 Mn
Mar 31, 2024 64.01 Mn
Mar 31, 2023 50.64 Mn
Mar 31, 2023 50.64 Mn